nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinical and laboratory scoring system for DIC in the field of obstetrics
|
Terao, T. |
|
1986 |
41 |
S1 |
p. 155- 1 p. |
artikel |
2 |
A comparison of the surface expression of platelet fibrinogen with the binding of plasma fibrinogen to activated platelets
|
Legrand, C. |
|
1986 |
41 |
S1 |
p. 71- 1 p. |
artikel |
3 |
Activation and desensitization of the endoperoxide/thromboxane platelet receptor
|
|
|
1986 |
41 |
S1 |
p. 15- 1 p. |
artikel |
4 |
Activation and inhibition of platelet aggregation by two distinct anti-human platelet monoclonal antibodies
|
|
|
1986 |
41 |
S1 |
p. 61- 1 p. |
artikel |
5 |
Acute hypoxemia due to respiratory insufficiency does not increase blood fibrinolytic activity
|
Stegnar, M. |
|
1986 |
41 |
S1 |
p. 111- 1 p. |
artikel |
6 |
Adhesive protein interaction with platelets
|
|
|
1986 |
41 |
S1 |
p. 7- 1 p. |
artikel |
7 |
Adhesive proteins and their receptors
|
|
|
1986 |
41 |
S1 |
p. 123- 1 p. |
artikel |
8 |
A human, heat-treated thrombin preparation for clinical and technical use
|
Feldman, P.A. |
|
1986 |
41 |
S1 |
p. 36- 1 p. |
artikel |
9 |
Alteration of von Willebrand factor (vWF) subunit composition in factor VIII concentrates
|
|
|
1986 |
41 |
S1 |
p. 103- 1 p. |
artikel |
10 |
A method for high resolution study of the mechanisms of blood flow in small blood vessels
|
|
|
1986 |
41 |
S1 |
p. 47- 1 p. |
artikel |
11 |
A new case of severe homozygote congenital factor VII deficiency
|
|
|
1986 |
41 |
S1 |
p. 38- 1 p. |
artikel |
12 |
A new clinically applicable technique for the direct measurement of white cell rheology
|
|
|
1986 |
41 |
S1 |
p. 47- 1 p. |
artikel |
13 |
A new experimental model of venous thrombosis in the rats
|
Millet, J. |
|
1986 |
41 |
S1 |
p. 81- 1 p. |
artikel |
14 |
A new ion-exchange procedure for the preparation of prothrombin complex concentrate
|
Feldman, P.A. |
|
1986 |
41 |
S1 |
p. 36- 1 p. |
artikel |
15 |
An integrated scheme for the purification of glycoproteins GP Ib, IIb, IIIa and IV from human platelets
|
|
|
1986 |
41 |
S1 |
p. 70- 1 p. |
artikel |
16 |
A novel method to differentiate cell adhesion and aggregation of whole blood on extracellular matrix seeded with endothelial cells
|
Eisert, W.G. |
|
1986 |
41 |
S1 |
p. 44- 1 p. |
artikel |
17 |
Antibodies to phospholipids prevent collagen-induced thromboxane B2 formation and platelet aggregation
|
|
|
1986 |
41 |
S1 |
p. 78- 1 p. |
artikel |
18 |
Anticoagulant treatment of pregnant women with a lupus anticoagulant (LA)
|
|
|
1986 |
41 |
S1 |
p. 76- 1 p. |
artikel |
19 |
Antiplatelets antibodies in systemic lupus erythematosus (S.L.E.)
|
Kaplan, C. |
|
1986 |
41 |
S1 |
p. 23- 1 p. |
artikel |
20 |
Antiplatelet treatment (Ditazol) in the bladder cancer
|
|
|
1986 |
41 |
S1 |
p. 143- 1 p. |
artikel |
21 |
Antithrombin III and protein C in retinal vein thrombosis
|
|
|
1986 |
41 |
S1 |
p. 59- 1 p. |
artikel |
22 |
Antithrombin III measurement in serum and plasma by laser nephelometry may lead to controversial results
|
Hopmeier, P. |
|
1986 |
41 |
S1 |
p. 50- 1 p. |
artikel |
23 |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties
|
|
|
1986 |
41 |
S1 |
p. 148- 1 p. |
artikel |
24 |
Anti-Xa plasma activity in liver cirrhosis:Relation with antithrombin III and alpha1-antitripsin
|
Cordova, C. |
|
1986 |
41 |
S1 |
p. 52- 1 p. |
artikel |
25 |
A passive platelet-fibrin interaction
|
|
|
1986 |
41 |
S1 |
p. 166- 1 p. |
artikel |
26 |
A plasmin-like, neutral, calcium dependent protease is responsible for the loss of the high molecular weight (HMW) multimers in the carbohydrate (CHO) modified von Willebrand factor (VWF)
|
Federici, A.B. |
|
1986 |
41 |
S1 |
p. 140- 1 p. |
artikel |
27 |
Application of a photometric fibrinogen assay to automated kinetic analyzers
|
|
|
1986 |
41 |
S1 |
p. 30- 1 p. |
artikel |
28 |
Arterial microfibrils thrombogenicity : Involvement of a thrombospondin-like structure
|
|
|
1986 |
41 |
S1 |
p. 55- 1 p. |
artikel |
29 |
A simple experimental model of thrombolysis in the rat: Effect of urokinase and streptokinase
|
Bernat, A. |
|
1986 |
41 |
S1 |
p. 112- 1 p. |
artikel |
30 |
Aspirin insensitive ATP-secretion occurs as an initial response at platelet collagen contact
|
Malmgren, Rigmor |
|
1986 |
41 |
S1 |
p. 166- 1 p. |
artikel |
31 |
Assay for activated protein C using a photometric apit test
|
|
|
1986 |
41 |
S1 |
p. 137- 1 p. |
artikel |
32 |
Association nifedipine-dipiridamol on platelets in ischemic heart disease
|
|
|
1986 |
41 |
S1 |
p. 141- 1 p. |
artikel |
33 |
A study of the anti-thrombotic potential of a low molecular weight heparin fragment CY222 given intravenously to normal volunteers
|
Johnston, R.V. |
|
1986 |
41 |
S1 |
p. 75- 1 p. |
artikel |
34 |
Author index
|
|
|
1986 |
41 |
S1 |
p. 175-191 17 p. |
artikel |
35 |
Behaviour of factor XIII subunits in neoplasm
|
|
|
1986 |
41 |
S1 |
p. 41- 1 p. |
artikel |
36 |
Binding of heparin to endothelial cells
|
van Rijn, J.L.M.L. |
|
1986 |
41 |
S1 |
p. 93- 1 p. |
artikel |
37 |
Bleeding and antithrombotic effects of a low molecular weight heparin (LMW/OP 2123)
|
Parma, B. |
|
1986 |
41 |
S1 |
p. 95- 1 p. |
artikel |
38 |
Blood coagulation changes in patients with acute lymphoblastic leukemia (all) treated with L-asparaginase
|
|
|
1986 |
41 |
S1 |
p. 40- 1 p. |
artikel |
39 |
Blood component treatment for haemostasis
|
Bloom, A.L. |
|
1986 |
41 |
S1 |
p. 13- 1 p. |
artikel |
40 |
Calcium protects the IIb-IIIa complex from chymotrypsin degradation
|
McGregor, J.L. |
|
1986 |
41 |
S1 |
p. 70- 1 p. |
artikel |
41 |
Ca2+ liberation by IP3: Mechanism of regulation
|
Enouf, J. |
|
1986 |
41 |
S1 |
p. 8- 1 p. |
artikel |
42 |
Can low dose heparin be helpful in the prevention of active angina?
|
Neri Serneri, G.G. |
|
1986 |
41 |
S1 |
p. 161- 1 p. |
artikel |
43 |
Cation complexation at the antithrombin-binding site may differ from that occurring in other parts of heparin
|
|
|
1986 |
41 |
S1 |
p. 92- 1 p. |
artikel |
44 |
Cellular elements of blood and fibrin network structure
|
Nair, C.H. |
|
1986 |
41 |
S1 |
p. 32- 1 p. |
artikel |
45 |
Characterization of fibrinogen Barcelona 1 (FB): Congenital dysfibrinogenemia with defective release of fibrinopeptide A and abnormal plasmic degradation
|
Vila, V. |
|
1986 |
41 |
S1 |
p. 31- 1 p. |
artikel |
46 |
Characterization of human protein S
|
Bouma, B.N. |
|
1986 |
41 |
S1 |
p. 135- 1 p. |
artikel |
47 |
Characterization of monoclonal antibodies against antithrombin III
|
|
|
1986 |
41 |
S1 |
p. 51- 1 p. |
artikel |
48 |
Characterization of platelets from a patient showing a lack of fibrinogen binding but aggregating to thrombin and collagen
|
McGregor, J.L. |
|
1986 |
41 |
S1 |
p. 26- 1 p. |
artikel |
49 |
Chemical cross-linking of human α-thrombin to platelet membrane receptors
|
|
|
1986 |
41 |
S1 |
p. 72- 1 p. |
artikel |
50 |
Chemically induced venous thrombosis of esophageal varices is not accompanied with changes in hemostatic parameters
|
|
|
1986 |
41 |
S1 |
p. 80- 1 p. |
artikel |
51 |
Chemically modified heparins of defined structure
|
Moffat, C.F |
|
1986 |
41 |
S1 |
p. 92- 1 p. |
artikel |
52 |
Clinical and laboratory studies on patients with lupus anticoagulant
|
|
|
1986 |
41 |
S1 |
p. 97- 1 p. |
artikel |
53 |
Clinical pharmacology of a new preparation of low molecular weight heparin
|
Palareti, G. |
|
1986 |
41 |
S1 |
p. 68- 1 p. |
artikel |
54 |
Clinical trials with low-molecular weight heparin in venous thrombosis
|
|
|
1986 |
41 |
S1 |
p. 67- 1 p. |
artikel |
55 |
Coagulation disturbances and their prognostic significance in lung cancer patients
|
Ponahajba, A. |
|
1986 |
41 |
S1 |
p. 158- 1 p. |
artikel |
56 |
Coagulation with copper and vitamin C
|
|
|
1986 |
41 |
S1 |
p. 31- 1 p. |
artikel |
57 |
Combination of stimuli and/or inhibitors in the regulation of platelet function
|
|
|
1986 |
41 |
S1 |
p. 14- 1 p. |
artikel |
58 |
Comparative evaluation of 3 automated coagulation instruments
|
Houbouyan, L.L. |
|
1986 |
41 |
S1 |
p. 34- 1 p. |
artikel |
59 |
Comparative pharmacokinetics of a low molecular weight heparin (LHN-1, NOVO) and conventional heparin after intravenous injection
|
|
|
1986 |
41 |
S1 |
p. 89- 1 p. |
artikel |
60 |
Comparison of human umbilical artery and rabbit abdominal aorta as substrata to study thrombus formation in flowing blood
|
Bastida, E. |
|
1986 |
41 |
S1 |
p. 134- 1 p. |
artikel |
61 |
Comparison of protein C assays
|
|
|
1986 |
41 |
S1 |
p. 162- 1 p. |
artikel |
62 |
Conformation equilibria of the γ chain cooh-terminus of human fibrinogen
|
|
|
1986 |
41 |
S1 |
p. 5- 1 p. |
artikel |
63 |
Congenital antithrombin (AT) III deficiency - thromboprophylaxis with at III concentrate during pregnancy and delivery
|
Tengborn, L. |
|
1986 |
41 |
S1 |
p. 49- 1 p. |
artikel |
64 |
Congenital deficiency of prothrombin and stuart-prower factor
|
Hajnž|≲ić, T.F. |
|
1986 |
41 |
S1 |
p. 37- 1 p. |
artikel |
65 |
Construction of a full-length von Willebrand factor (VWF) cDNA
|
Verweij, C.L. |
|
1986 |
41 |
S1 |
p. 138- 1 p. |
artikel |
66 |
Contribution of heparin endothelial cell binding to its inactivation
|
Bârzu, T. |
|
1986 |
41 |
S1 |
p. 116- 1 p. |
artikel |
67 |
Contributions of molecular biology to the study of hemostasis
|
|
|
1986 |
41 |
S1 |
p. 65- 1 p. |
artikel |
68 |
Controlled clinical trial of ticlopidine in patients suffering from intermittent claudication
|
Arcan, J.C. |
|
1986 |
41 |
S1 |
p. 159- 1 p. |
artikel |
69 |
Covalent crosslinking of factor V by megakaryocyte transglutaminase and factor XIIa
|
|
|
1986 |
41 |
S1 |
p. 35- 1 p. |
artikel |
70 |
Covalent hybrid plasminogen activator
|
Robbins, K.C. |
|
1986 |
41 |
S1 |
p. 19- 1 p. |
artikel |
71 |
Critical review of clinical trials with: rt-PA
|
|
|
1986 |
41 |
S1 |
p. 128- 1 p. |
artikel |
72 |
CY 216, new low molecular weight heparin fraction : Antithrombotic properties in experimental models and in clinical trials
|
Frapaise, F.X. |
|
1986 |
41 |
S1 |
p. 96- 1 p. |
artikel |
73 |
Decrease of clumping of platelets and red cells, from patients with heart disease or cancer, uner zero gravity
|
|
|
1986 |
41 |
S1 |
p. 171- 1 p. |
artikel |
74 |
Deep vein thrombosis and asymptomatic pulmonary embolism
|
Monreal, M. |
|
1986 |
41 |
S1 |
p. 80- 1 p. |
artikel |
75 |
Demonstration of hypercoagulability during contraceptive drug treatment
|
Inauen, W. |
|
1986 |
41 |
S1 |
p. 114- 1 p. |
artikel |
76 |
Demostration of hipercoagulability in patients with mediterranean spotted fever
|
Vicente, V. |
|
1986 |
41 |
S1 |
p. 156- 1 p. |
artikel |
77 |
Detection of lupus anticoagulant in patients under oral anticoagulant treatment
|
|
|
1986 |
41 |
S1 |
p. 98- 1 p. |
artikel |
78 |
Diagnosis of deep venous thrombosis : Value of real time B mode ultrasound imaging and continuous wave doppler (echography-doppler) compared to venography
|
|
|
1986 |
41 |
S1 |
p. 75- 1 p. |
artikel |
79 |
Dipyridamole and platelet aggregation in whole blood
|
|
|
1986 |
41 |
S1 |
p. 149- 1 p. |
artikel |
80 |
Dipyridamole induced rectal bleeding
|
Lewinski, U.H. |
|
1986 |
41 |
S1 |
p. 29- 1 p. |
artikel |
81 |
Discriminant analysis and bayes' theorem in decision making for pulmonary thromboembolism
|
Petruzzelli, S. |
|
1986 |
41 |
S1 |
p. 73- 1 p. |
artikel |
82 |
Disseminated carcinomatosis of the bone marrow (DCBM) as a distinct variety of cancer metastases—with reference to disseminated intravascular coagulation (DIC) as a complication of DCBM
|
|
|
1986 |
41 |
S1 |
p. 154- 1 p. |
artikel |
83 |
Disseminated intravascular coagulation. New approaches to diagnosis and treatment
|
Preston, F.E. |
|
1986 |
41 |
S1 |
p. 12- 1 p. |
artikel |
84 |
Dissolution of “ex vivo” thrombi by tissue plasminogen activator, streptokinase and urokinase
|
|
|
1986 |
41 |
S1 |
p. 109- 1 p. |
artikel |
85 |
Diurnal fluctuation of tissue plasminogen activator: Effects of recumbency and parenteral nutrition
|
Keber, D. |
|
1986 |
41 |
S1 |
p. 109- 1 p. |
artikel |
86 |
Do changes in the haemostatic system reflect the presence and/or the extent of coronary sclerosis?
|
Schmitz-Huebner, U. |
|
1986 |
41 |
S1 |
p. 113- 1 p. |
artikel |
87 |
Does phlebography permit the prediction of the efficiency of the thrombolytic therapy?
|
|
|
1986 |
41 |
S1 |
p. 107- 1 p. |
artikel |
88 |
Double-blind clinical trial of ticlopidine versus placebo in peripheral atherosclerotic disease of the legs
|
|
|
1986 |
41 |
S1 |
p. 160- 1 p. |
artikel |
89 |
Early biochemical events in thrombin-induced activation of normal and pathological platelets
|
Rendu, F. |
|
1986 |
41 |
S1 |
p. 8- 1 p. |
artikel |
90 |
Early platelet-collagen interactions in whole blood studied by a new method (basic wave): Experiencies with dipiridamole ex vivo in the presence of absence of extracellular calcium
|
|
|
1986 |
41 |
S1 |
p. 14- 1 p. |
artikel |
91 |
Editorial Board
|
|
|
1986 |
41 |
S1 |
p. v- 1 p. |
artikel |
92 |
Effective lysis of old venous thrombi in the rabbit with recombinant single-chain tissue-type plasminogen activator (t-PA)
|
Baldus, B. |
|
1986 |
41 |
S1 |
p. 112- 1 p. |
artikel |
93 |
Effectiveness of longterm oral anticoagulant treatment in preventing thrombosis in hereditary protein S deficiency
|
Michiels, J.J. |
|
1986 |
41 |
S1 |
p. 136- 1 p. |
artikel |
94 |
Effect of acenocoumarol on platelet activity of patients with chronic heart disease
|
Fernández, M.A. |
|
1986 |
41 |
S1 |
p. 164- 1 p. |
artikel |
95 |
Effect of adrenoceptors on the molecular and cellular responses induced by thrombin
|
|
|
1986 |
41 |
S1 |
p. 171- 1 p. |
artikel |
96 |
Effect of BN 52021, a new PAF-receptor antagonist, on the rat tail bleeding time
|
|
|
1986 |
41 |
S1 |
p. 148- 1 p. |
artikel |
97 |
Effect of [Ca2+] in the suspending medium on the ability of von Willebrand factor and fibrinogen to support ADP-induced aggregation of human platelets
|
|
|
1986 |
41 |
S1 |
p. 121- 1 p. |
artikel |
98 |
Effect of dyslipemia associated or unassociated with acute myocardial infarction (AMI) on angor pectoris in blood filterability
|
|
|
1986 |
41 |
S1 |
p. 155- 1 p. |
artikel |
99 |
Effect of endotoxin (E) on plasma thromboxane B2 (TXB2) level and prostacyclin (PGI2) release from vessel walls, lungs and kidneys in rabbits and on human platelet function
|
|
|
1986 |
41 |
S1 |
p. 45- 1 p. |
artikel |
100 |
Effect of exhaustion on the enzymatic systems that regulate synthesis of PGI2 in rat aorta
|
|
|
1986 |
41 |
S1 |
p. 44- 1 p. |
artikel |
101 |
Effect of Formosn cobra (
Naja naja atra
) venom phospholipase A2 on platelet aggregation and blood coagulation
|
|
|
1986 |
41 |
S1 |
p. 168- 1 p. |
artikel |
102 |
Effect of haemodialysis on the prekallikrein system
|
Alegre, A. |
|
1986 |
41 |
S1 |
p. 39- 1 p. |
artikel |
103 |
Effect of pentosan-polysulfate on the haemorheological parameters in elderly patients. Possible role of leucocyte arachidonic acid metabolism
|
Freyburger, G. |
|
1986 |
41 |
S1 |
p. 46- 1 p. |
artikel |
104 |
Effect of propranolol, barbiturate anesthesia and splenectomy on factor VIIIC release induced by DDAVP. An experimental study in the dog
|
Pina-Cabral, J.M. |
|
1986 |
41 |
S1 |
p. 104- 1 p. |
artikel |
105 |
Effects of administration of ticlopidine and low dose-aspirin on platelet function in ischemic heart disease patients
|
Strano, Antonio |
|
1986 |
41 |
S1 |
p. 143- 1 p. |
artikel |
106 |
Effects of different antithrombotic (AT) agents (PGI2, heparin (H), CG 4203) on platelets and hemostasis during bicarbonate hemodialysis (HD)
|
|
|
1986 |
41 |
S1 |
p. 145- 1 p. |
artikel |
107 |
Effects of human antithrombin III (at III) and heparin on endotoxin-induced disseminated intravascular coagulation (DIC) in rabbits
|
Rocha, E. |
|
1986 |
41 |
S1 |
p. 58- 1 p. |
artikel |
108 |
Effects of OHo scavengers on platelet aggregation
|
Violi, F. |
|
1986 |
41 |
S1 |
p. 172- 1 p. |
artikel |
109 |
Efficiency of platelets radiolabelling is improved by prostacyclin
|
|
|
1986 |
41 |
S1 |
p. 167- 1 p. |
artikel |
110 |
Elisa evaluation of B-thromboglobulin and platelet factor 4
|
|
|
1986 |
41 |
S1 |
p. 170- 1 p. |
artikel |
111 |
Endothelial cell thrombospondin: Binding domains for fibronectin and heparin and Ca dependent structure
|
|
|
1986 |
41 |
S1 |
p. 54- 1 p. |
artikel |
112 |
Endothelial plasminogen activator inhibitor: A new member of the serpin gene family
|
Pannekoek, H. |
|
1986 |
41 |
S1 |
p. 20- 1 p. |
artikel |
113 |
Enzyme immunoassay for determination of human thrombin/antithrombin III complex
|
Pelzer, H. |
|
1986 |
41 |
S1 |
p. 51- 1 p. |
artikel |
114 |
Eosinophilia - a possible link to thrombosis and fibrosis
|
Lederman, J. |
|
1986 |
41 |
S1 |
p. 153- 1 p. |
artikel |
115 |
Epitopic specificity in identifying crosslinked (XL) fibrin derivatives by the monoclonal antibody (MAb) DD-3B6/22
|
Whitaker, A.N. |
|
1986 |
41 |
S1 |
p. 6- 1 p. |
artikel |
116 |
Evaluation in whole blood of the antiplatelet activity of dipyridamol and pentoxifylline with the basix wave
|
|
|
1986 |
41 |
S1 |
p. 149- 1 p. |
artikel |
117 |
Evaluation of human thrombopoiesis by examination of marrow megakaryocytes
|
|
|
1986 |
41 |
S1 |
p. 125- 1 p. |
artikel |
118 |
Evaluation of kinetic parameters of the interaction of human plasma kallikrein with aprotonin or ARG15-aprotonin using chromogenic microtechnology
|
|
|
1986 |
41 |
S1 |
p. 16- 1 p. |
artikel |
119 |
Evaluation of labsystems FP-910 coagulation analyzer designed for clotting, chromogenic and EIA methods
|
|
|
1986 |
41 |
S1 |
p. 34- 1 p. |
artikel |
120 |
Evaluation of serial impedance-plethysmography as a single diagnostic test in deep vein-thrombosis : A prospective study
|
|
|
1986 |
41 |
S1 |
p. 74- 1 p. |
artikel |
121 |
Evaluation of the plasma kinin system in mediterranean spotted fever
|
Vicente, V. |
|
1986 |
41 |
S1 |
p. 38- 1 p. |
artikel |
122 |
Evaluation of the thromboembolic risk in hereditary quantitative and qualitative antithrombin III (at III) deficiency by measurement of plasmatic fibrin degradation products (FDF) using a monoclonal anti-D-neo antibody - role of heparan sulphates in the antithrombotic action of at III
|
|
|
1986 |
41 |
S1 |
p. 53- 1 p. |
artikel |
123 |
Evidence for two conformational forms of heparins/heparans
|
|
|
1986 |
41 |
S1 |
p. 91- 1 p. |
artikel |
124 |
Expression and biological activity of synthetic beta-thromboglobulin-related antigen
|
|
|
1986 |
41 |
S1 |
p. 170- 1 p. |
artikel |
125 |
Factor IX conversion in plasma
|
|
|
1986 |
41 |
S1 |
p. 17- 1 p. |
artikel |
126 |
Factor VIII inhibitor in mild haemophilia
|
Capel, P. |
|
1986 |
41 |
S1 |
p. 43- 1 p. |
artikel |
127 |
Factor XIII and fibronectin in nephrotic syndrome
|
|
|
1986 |
41 |
S1 |
p. 39- 1 p. |
artikel |
128 |
Factor XIII-catalyzed polymeric assemblies in platelets
|
|
|
1986 |
41 |
S1 |
p. 121- 1 p. |
artikel |
129 |
Factor XIII of blood coagulation in tumor invading macrophages. Its possible involvement in intratumoral fibrin formation
|
|
|
1986 |
41 |
S1 |
p. 40- 1 p. |
artikel |
130 |
Feedback responses to thrombocytopenia
|
|
|
1986 |
41 |
S1 |
p. 124- 1 p. |
artikel |
131 |
Fibrinolysis in pregnancy
|
Kruithof, E.K.O. |
|
1986 |
41 |
S1 |
p. 21- 1 p. |
artikel |
132 |
Fibrinolytic activity of OP/LMWH in experimental venous thrombosis
|
Barbanti, M. |
|
1986 |
41 |
S1 |
p. 87- 1 p. |
artikel |
133 |
Fibrin-specific thrombolysis with tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator
|
|
|
1986 |
41 |
S1 |
p. 127- 1 p. |
artikel |
134 |
Follow up of acute deep venous thrombosis by real time B-mode ultrasound imaging and continuous wave doppler (Echography Doppler)
|
Elias, A |
|
1986 |
41 |
S1 |
p. 81- 1 p. |
artikel |
135 |
Free radical generation and arterial disease
|
|
|
1986 |
41 |
S1 |
p. 133- 1 p. |
artikel |
136 |
Functional and antigenic protein C and its inhibitor in normal pregnancy and preeclampsia
|
Gilabert, J. |
|
1986 |
41 |
S1 |
p. 162- 1 p. |
artikel |
137 |
Functional characterization of a monoclonal anti tissue type plasminogen activator (t-PA) antibody stimulating plasminogen activator activity of t-PA
|
Wojta, J. |
|
1986 |
41 |
S1 |
p. 19- 1 p. |
artikel |
138 |
Further experience with at III substitution in shock and DIC
|
|
|
1986 |
41 |
S1 |
p. 131- 1 p. |
artikel |
139 |
α-Granule deficiency (gray platelet syndrome) discovered in an elderly patient
|
|
|
1986 |
41 |
S1 |
p. 27- 1 p. |
artikel |
140 |
Haemorheological therapy by arachidonic acid in hepatic cirrhosis
|
Freyburger, G. |
|
1986 |
41 |
S1 |
p. 46- 1 p. |
artikel |
141 |
Hemorrhagic disorders in neonates
|
|
|
1986 |
41 |
S1 |
p. 11- 1 p. |
artikel |
142 |
Heparin catabolism by human vascular endothelial cells
|
|
|
1986 |
41 |
S1 |
p. 116- 1 p. |
artikel |
143 |
Heparin-DHE 3×5000 i.U. Versus acetylsalicylic acid 3×0.5 G plus 2.5 MG DHE as prophylaxis of thromboembolism in femoral fractures near by the hip joint
|
|
|
1986 |
41 |
S1 |
p. 85- 1 p. |
artikel |
144 |
Heparin induced osteoporosis in rats
|
|
|
1986 |
41 |
S1 |
p. 86- 1 p. |
artikel |
145 |
Heparinoid ORG 10172 in patients undergoing turp: a safety, study
|
ten Cate, H. |
|
1986 |
41 |
S1 |
p. 84- 1 p. |
artikel |
146 |
Heparin pharmacokinetics in deep venous thrombosis and in chronic renal insufficiency
|
|
|
1986 |
41 |
S1 |
p. 89- 1 p. |
artikel |
147 |
Heparin structural modifications and human platelet aggregation
|
Mastacchi, R. |
|
1986 |
41 |
S1 |
p. 87- 1 p. |
artikel |
148 |
Hereditary deficiency in heparin cofactor II (HeCoFII) and the risk for the development of thrombosis
|
Bertina, R.M. |
|
1986 |
41 |
S1 |
p. 59- 1 p. |
artikel |
149 |
Hereditary warfarin resistance
|
|
|
1986 |
41 |
S1 |
p. 164- 1 p. |
artikel |
150 |
Heterogeneity in type IIB von Willebrand disease: Two unrelated cases with no family history and mild abnormalities of ristocetin-induced interaction between von Willebrand factor and platelets
|
Federici, A.B. |
|
1986 |
41 |
S1 |
p. 101- 1 p. |
artikel |
151 |
Heterogeneity of type IIA von Willebrand Disease: Studies with protease inhibitor
|
Batlle, J. |
|
1986 |
41 |
S1 |
p. 140- 1 p. |
artikel |
152 |
Heterozygous protein C deficiency
|
|
|
1986 |
41 |
S1 |
p. 63- 1 p. |
artikel |
153 |
High dose immunoglobulin (IGG) therapy for idiopathic thrombocytopenic purpura (ITP) and its functional effects on platelets
|
Matsuda, J. |
|
1986 |
41 |
S1 |
p. 11- 1 p. |
artikel |
154 |
High-dose intravenous immunoglobulin for treatment of idiopathic thrombocytopenic purpura in children
|
Boguslawska-Jaworska, J. |
|
1986 |
41 |
S1 |
p. 22- 1 p. |
artikel |
155 |
High fibrinogen level and prolonged thrombin clotting time
|
Marongiu, F. |
|
1986 |
41 |
S1 |
p. 33- 1 p. |
artikel |
156 |
Homozygous protein C deficiency
|
Seligsohn, U. |
|
1986 |
41 |
S1 |
p. 64- 1 p. |
artikel |
157 |
How many patients with acute myocardial infarction could be treated in France by intravenous streptokinase ? Results of a prospective trial (enim 84)
|
|
|
1986 |
41 |
S1 |
p. 106- 1 p. |
artikel |
158 |
Human monocyte-macrophage (M-M) procoagulant activity (PCA)
|
|
|
1986 |
41 |
S1 |
p. 43- 1 p. |
artikel |
159 |
Human platelet membrane glycoprotein I has high affinity for collagen
|
|
|
1986 |
41 |
S1 |
p. 71- 1 p. |
artikel |
160 |
Identification and characterization of a defect of a homozygous factor XI deficient patient with cross-reacting material
|
Mannhalter, C. |
|
1986 |
41 |
S1 |
p. 17- 1 p. |
artikel |
161 |
Impedance plethysmography (IPG) in the diagnosis of deep vein thrombosis (DVT) in an urban hospital setting
|
|
|
1986 |
41 |
S1 |
p. 82- 1 p. |
artikel |
162 |
Increased plasma levels of antithrombin-III (at-III) in coronary patients
|
|
|
1986 |
41 |
S1 |
p. 52- 1 p. |
artikel |
163 |
Indobufen activity on intraplatelet arachidonic acid metabolism
|
Abbate, R. |
|
1986 |
41 |
S1 |
p. 144- 1 p. |
artikel |
164 |
Induction of tolerance in four high-responding haemophiliacs with facor IX antibodies
|
Nilsson, I.M. |
|
1986 |
41 |
S1 |
p. 35- 1 p. |
artikel |
165 |
Influence of kinetics of network growth on fibrin network structure
|
Shah, G.A. |
|
1986 |
41 |
S1 |
p. 32- 1 p. |
artikel |
166 |
Influence of membrane cholesterol content on platelet procoagulant activity
|
Zwaal, R.F.A. |
|
1986 |
41 |
S1 |
p. 1- 1 p. |
artikel |
167 |
Inhibition of collagen-induced platelet activation by 5′-p-fluorosulfonylbenzoyl adenosine : Evidence for an ADP requirement and synergistic influence of prostaglandin endoperoxides
|
|
|
1986 |
41 |
S1 |
p. 62- 1 p. |
artikel |
168 |
Inhibition of experimental arterial and venous thrombosis by the novel pyridazinone-derivative, C85-3143
|
|
|
1986 |
41 |
S1 |
p. 147- 1 p. |
artikel |
169 |
Inhibition of heparitinase mediated degradation of extracellular matrix heparan sulfate by non anticoagulant heparin species
|
|
|
1986 |
41 |
S1 |
p. 117- 1 p. |
artikel |
170 |
Inhibition of human platelet function and thromboxane B2(TXB2) synthesis and prostacyclin (PGI2) release from rabbit aortic rings by nifedipine
|
|
|
1986 |
41 |
S1 |
p. 150- 1 p. |
artikel |
171 |
Inhibition of tyloxapol (triton WR 1339) enhanced venous thrombosis by low molecular weight heparin (OP 2123)
|
Bianchini, P. |
|
1986 |
41 |
S1 |
p. 94- 1 p. |
artikel |
172 |
Inhibition of von Willebrand factor binding to activated platelets by the tetrapeptide ARG-GLY-ASP-SER and the dodecapeptide of fibrinogen gamma chains
|
|
|
1986 |
41 |
S1 |
p. 139- 1 p. |
artikel |
173 |
Inhibitory effect of SIN 1 on platelet function : Possible interference with platelet phosphorylations and fibrinogen binding
|
Weill, D. |
|
1986 |
41 |
S1 |
p. 60- 1 p. |
artikel |
174 |
Interaction of actin filaments with platelet membranes
|
|
|
1986 |
41 |
S1 |
p. 7- 1 p. |
artikel |
175 |
Interaction of endothelial cells and the vessel wall
|
|
|
1986 |
41 |
S1 |
p. 122- 1 p. |
artikel |
176 |
Intraplatelet levels on von Willebrand antigen (VWAg) and fibrinogen (I) in myeloproliferative syndromes
|
|
|
1986 |
41 |
S1 |
p. 103- 1 p. |
artikel |
177 |
Intravenous thrombolytic therapy of acute myocardial infarction
|
Seyfert, U.T. |
|
1986 |
41 |
S1 |
p. 105- 1 p. |
artikel |
178 |
In vivo
platelet function in diabetes mellitus
|
Stegmann, J.A |
|
1986 |
41 |
S1 |
p. 25- 1 p. |
artikel |
179 |
Is beta-thromboglobulin of prognostic value in patients with transient cerebral ischaemia ?
|
Davi, Giovanni |
|
1986 |
41 |
S1 |
p. 158- 1 p. |
artikel |
180 |
LAV/HTLV III antibodies in swedish haemophiliacs; in relation to type and dosage of factor concentrate
|
Berntorp, E. |
|
1986 |
41 |
S1 |
p. 18- 1 p. |
artikel |
181 |
Levels of platelet reactivity and patency rate of coronary bypass in a ticlopidine-placebo double blind study
|
David, J.L. |
|
1986 |
41 |
S1 |
p. 141- 1 p. |
artikel |
182 |
LMW heparin (OP 2123): In vitro and in vivo protamine interaction
|
Bianchini, P. |
|
1986 |
41 |
S1 |
p. 94- 1 p. |
artikel |
183 |
Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia
|
|
|
1986 |
41 |
S1 |
p. 90- 1 p. |
artikel |
184 |
Lupus anticoagulant inhibits the thrombomodulin dependent activation of protein C by human endothelial cells
|
Cariou, R. |
|
1986 |
41 |
S1 |
p. 78- 1 p. |
artikel |
185 |
Lupus anticoagulant (L.A.) : Clinical features of 61 cases
|
|
|
1986 |
41 |
S1 |
p. 76- 1 p. |
artikel |
186 |
Macroglobulinemia associated with a lupus like anticoagulant and false elevated FDP level
|
Capel, P. |
|
1986 |
41 |
S1 |
p. 99- 1 p. |
artikel |
187 |
Measurement of D.Dimer with an enzyme-immuno-assay
|
|
|
1986 |
41 |
S1 |
p. 33- 1 p. |
artikel |
188 |
MEFS, mediterranean erythrocyte filtration study on essential hypertension
|
|
|
1986 |
41 |
S1 |
p. 48- 1 p. |
artikel |
189 |
Megakaryocyte colony stimulating activity (MK-CSA) and megakaryocyte progenitors (CFU-MK) in bone marrow transplantation
|
|
|
1986 |
41 |
S1 |
p. 124- 1 p. |
artikel |
190 |
Megakaryocyte - vessel wall interaction
|
Eldor, A. |
|
1986 |
41 |
S1 |
p. 122- 1 p. |
artikel |
191 |
Metabolism of antithrombin III·Protease complexes by various cells in culture
|
|
|
1986 |
41 |
S1 |
p. 129- 1 p. |
artikel |
192 |
Modulation of adhesive proteins in the matrix by endothelial cells
|
de Groot, Philip G. |
|
1986 |
41 |
S1 |
p. 123- 1 p. |
artikel |
193 |
Molecular biology of von Willebrand factor and implications for its structure-function relationships
|
|
|
1986 |
41 |
S1 |
p. 65- 1 p. |
artikel |
194 |
Molecular genetics of haemophilia
|
|
|
1986 |
41 |
S1 |
p. 66- 1 p. |
artikel |
195 |
Monitoring the therapy with antithrombin III concentrates
|
|
|
1986 |
41 |
S1 |
p. 130- 1 p. |
artikel |
196 |
Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulphate in rats
|
|
|
1986 |
41 |
S1 |
p. 86- 1 p. |
artikel |
197 |
N-methyl-thiotetrazole cephalosporins inhibit vitamin K metabolism of coagulation proteins
|
Mackie, I.J. |
|
1986 |
41 |
S1 |
p. 42- 1 p. |
artikel |
198 |
No significant effect of chronic aspirin use on tissue plasminogen activator release during arm venous occlusion in coronary patients
|
Keber, I. |
|
1986 |
41 |
S1 |
p. 110- 1 p. |
artikel |
199 |
Occult thyrotoxicosis in patients with atrial fibrillation and secondary arterial embolism
|
|
|
1986 |
41 |
S1 |
p. 152- 1 p. |
artikel |
200 |
On the role of guanine nucleotide binding regulatory proteins (G-proteins) in signal transduction in platelets; studies with sodium fluoride (NaF)
|
Kienast, J. |
|
1986 |
41 |
S1 |
p. 120- 1 p. |
artikel |
201 |
Open problems in prevention and treatment of thromboembolism. An introduction
|
|
|
1986 |
41 |
S1 |
p. 67- 1 p. |
artikel |
202 |
Optimal dosage regimens with tissue plasminogen activator
|
|
|
1986 |
41 |
S1 |
p. 69- 1 p. |
artikel |
203 |
Partial identification of a plasmatic factor stimulating prostacyclin production in rat smooth muscle cells
|
de Castellarnau, C. |
|
1986 |
41 |
S1 |
p. 45- 1 p. |
artikel |
204 |
Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas
|
Kirchheimer, J.C. |
|
1986 |
41 |
S1 |
p. 108- 1 p. |
artikel |
205 |
PCR 4099. A new antithrombotic drug. Evaluation of tolerance and of pharmacological activity
|
|
|
1986 |
41 |
S1 |
p. 144- 1 p. |
artikel |
206 |
Pentosane polysulfate like heparin may induce severe thrombocytopenia
|
Le Querrec, A. |
|
1986 |
41 |
S1 |
p. 90- 1 p. |
artikel |
207 |
Performances of a new clot based functional protein C assay
|
Martinoli, J.L. |
|
1986 |
41 |
S1 |
p. 163- 1 p. |
artikel |
208 |
Peripheral blood mononuclear cell fibrinolytic activity (FA) serum inhibition is reversed by both heating at 56°C and heparin
|
Ghezzo, F. |
|
1986 |
41 |
S1 |
p. 111- 1 p. |
artikel |
209 |
Peripheral vascular symptoms as the initial manifestation of thrombocythemia vera
|
|
|
1986 |
41 |
S1 |
p. 115- 1 p. |
artikel |
210 |
PGI2 platelet receptors are affected by cholesterol/phospholipid molar ratio
|
Modesti, P.A. |
|
1986 |
41 |
S1 |
p. 72- 1 p. |
artikel |
211 |
Pharmacokinetics of a low molecular weight heparin compared with standard heparin
|
Mätzsch, T. |
|
1986 |
41 |
S1 |
p. 118- 1 p. |
artikel |
212 |
Pharmacological aspects and laboratory control of thrombolytic agents
|
|
|
1986 |
41 |
S1 |
p. 127- 1 p. |
artikel |
213 |
Plasma inhibition of thromboplastin-mediated blood coagulation
|
|
|
1986 |
41 |
S1 |
p. 57- 1 p. |
artikel |
214 |
Platelet activation and bleeding time in female fawn hooded rats depending on their sexual cycle
|
Kirchmaier, C.M. |
|
1986 |
41 |
S1 |
p. 169- 1 p. |
artikel |
215 |
Platelet activity during coronary angiography
|
|
|
1986 |
41 |
S1 |
p. 24- 1 p. |
artikel |
216 |
Platelet activity in normal children and children with stroke
|
|
|
1986 |
41 |
S1 |
p. 24- 1 p. |
artikel |
217 |
Platelet aggregation in fawn hooded rats : Evidence that PCR 4099 inhibits selectively the platelet ADP pathway
|
|
|
1986 |
41 |
S1 |
p. 146- 1 p. |
artikel |
218 |
Platelet aggregation is enhanced in hypertriglyceridemias
|
Riess, H. |
|
1986 |
41 |
S1 |
p. 2- 1 p. |
artikel |
219 |
Platelet and plasma von Willebrand factor in normal and IIC von Willebrand's disease
|
López-Fernández, M.F. |
|
1986 |
41 |
S1 |
p. 100- 1 p. |
artikel |
220 |
Platelet arachidonic acid metabolism in angina pectoris
|
Neri Serneri, G.G. |
|
1986 |
41 |
S1 |
p. 160- 1 p. |
artikel |
221 |
Platelet at III in normals and in pathologic conditions
|
|
|
1986 |
41 |
S1 |
p. 129- 1 p. |
artikel |
222 |
Platelet count and platelet aggregation in inflammatory bowel disease in response to the disease activity
|
Krause, W.H. |
|
1986 |
41 |
S1 |
p. 25- 1 p. |
artikel |
223 |
Platelet function and sensitivity to prostacyclin (PGI2), platelet survival time (PST) and plasma thromboxane B2 (TXB2) level in chronic obstructive arterial disease (COAD)
|
|
|
1986 |
41 |
S1 |
p. 15- 1 p. |
artikel |
224 |
Platelet ihibitors in arterial thrombosis and atherogenesis
|
|
|
1986 |
41 |
S1 |
p. 69- 1 p. |
artikel |
225 |
Platelet mediated arteriolar smooth muscle cell proliferation and migration in erythromelalgic; thrombotic thrombocythemia vera: Ultrastructural evidence
|
|
|
1986 |
41 |
S1 |
p. 157- 1 p. |
artikel |
226 |
Platelet parameters and aggregation in essential (ET) and reactive (RT) thrombocytosis
|
|
|
1986 |
41 |
S1 |
p. 23- 1 p. |
artikel |
227 |
Platelet phospholipids in hemostasis and thrombosis
|
Zwaal, R.F.A. |
|
1986 |
41 |
S1 |
p. 10- 1 p. |
artikel |
228 |
Platelet protein S
|
|
|
1986 |
41 |
S1 |
p. 64- 1 p. |
artikel |
229 |
Platelet secretion defect and impaired synthesis or response of thromboxane A2 in a patient with a bleeding disorder
|
de Castellarnau, C. |
|
1986 |
41 |
S1 |
p. 28- 1 p. |
artikel |
230 |
Platelet subpopulations: External to invaginated plasma membrane surface area is constant, independent of size
|
|
|
1986 |
41 |
S1 |
p. 119- 1 p. |
artikel |
231 |
Platelet thrombospondin is non-thrombogenic
|
|
|
1986 |
41 |
S1 |
p. 56- 1 p. |
artikel |
232 |
Platelet-vessel wall interaction - new data
|
|
|
1986 |
41 |
S1 |
p. 122- 1 p. |
artikel |
233 |
Platelet von Willebrand factor: An important determinant of the bleeding time in type I von Willebrand's disease
|
Gralnick, H.R. |
|
1986 |
41 |
S1 |
p. 102- 1 p. |
artikel |
234 |
Positive effect on haemostasis by 1-deamino-8-D-arginine vasopressin (DDAVP) in congenital platelet function defects
|
Schulman, S. |
|
1986 |
41 |
S1 |
p. 27- 1 p. |
artikel |
235 |
Possible prevention of cardiovascular complications in patients with intermittent claudication
|
|
|
1986 |
41 |
S1 |
p. 60- 1 p. |
artikel |
236 |
Pregnancy induced hypertension and hemostasis
|
Saleh, A.A. |
|
1986 |
41 |
S1 |
p. 98- 1 p. |
artikel |
237 |
Prekallikrein, hageman factor, and high molecular weight kininogen in liver cirrhosis
|
Cordova, C. |
|
1986 |
41 |
S1 |
p. 41- 1 p. |
artikel |
238 |
Prekallikrein-kinin system in early acute myocardial infarction
|
|
|
1986 |
41 |
S1 |
p. 156- 1 p. |
artikel |
239 |
Prenatal diagnosis and carrier determination in haemophilia B using three gene-specific polymorphic DNA markers
|
Giannelli, F. |
|
1986 |
41 |
S1 |
p. 18- 1 p. |
artikel |
240 |
Prevalence of protein C (PC) and protein S (PS) deficiency in patients with thrombotic disease
|
Broekmans, A.W. |
|
1986 |
41 |
S1 |
p. 135- 1 p. |
artikel |
241 |
Prevention of aortocoronary bypass occlusion. Beneficial effects of ticlopidine on early and late patency rates of coronary bypass grafts : A double blind study
|
|
|
1986 |
41 |
S1 |
p. 62- 1 p. |
artikel |
242 |
Prevention of thrombosis in critical arterial prostheses by defibrination
|
Dormandy, J.A. |
|
1986 |
41 |
S1 |
p. 159- 1 p. |
artikel |
243 |
Prevention of thrombosis in critical arterial prostheses by lowering red cell concentration
|
|
|
1986 |
41 |
S1 |
p. 114- 1 p. |
artikel |
244 |
Procoagulant activity of a human T lymphoma cell line
|
|
|
1986 |
41 |
S1 |
p. 16- 1 p. |
artikel |
245 |
Progress in the diagnosis and treatment of acquired Von Willebrand's syndrome (AVWS)
|
|
|
1986 |
41 |
S1 |
p. 12- 1 p. |
artikel |
246 |
Properties of phospholipid bilayer membranes and their relationship to phospholipid function in blood clotting
|
|
|
1986 |
41 |
S1 |
p. 9- 1 p. |
artikel |
247 |
Prospective randomized controlled trial of intravenous streptokinase in acute myocardial infarction
|
|
|
1986 |
41 |
S1 |
p. 106- 1 p. |
artikel |
248 |
Protamine neutralization of a very low molecular weight heparin fragment CY 222 in vitro and in vivo study
|
Doutremepuich, C. |
|
1986 |
41 |
S1 |
p. 88- 1 p. |
artikel |
249 |
Protamine neutralization of the thrombolytic activity of a very low molecular weight heparin fragment (VLMW) CY 222
|
Vairel, E.G. |
|
1986 |
41 |
S1 |
p. 88- 1 p. |
artikel |
250 |
Protein C and fibrinolisis
|
|
|
1986 |
41 |
S1 |
p. 64- 1 p. |
artikel |
251 |
Protein C and S antigens in glomerular nephropathy and nephrotic syndrome
|
|
|
1986 |
41 |
S1 |
p. 163- 1 p. |
artikel |
252 |
Protein C (PC) and coumarin-induced skin necrosis
|
Broekmans, A.W. |
|
1986 |
41 |
S1 |
p. 137- 1 p. |
artikel |
253 |
Protein S deficiency
|
|
|
1986 |
41 |
S1 |
p. 64- 1 p. |
artikel |
254 |
Protein S deficiency in 7 Austrian families
|
|
|
1986 |
41 |
S1 |
p. 136- 1 p. |
artikel |
255 |
Proteolytic degradation of fibronectin by plasmin stimulates human neutrophil degranulation
|
|
|
1986 |
41 |
S1 |
p. 56- 1 p. |
artikel |
256 |
Rapid and complete degradation of thymidine by human peripheral blood platelets: Implications for genotoxicity assays
|
|
|
1986 |
41 |
S1 |
p. 167- 1 p. |
artikel |
257 |
Reduced plasma high-density lipoprotein (HDL) and increased platelet activity in arterial vs. venous blood
|
Aviram, M. |
|
1986 |
41 |
S1 |
p. 2- 1 p. |
artikel |
258 |
Reduction of the atherosclerosis risk factors in Legazpia by an intervention trial
|
Iriarte, J.A. |
|
1986 |
41 |
S1 |
p. 157- 1 p. |
artikel |
259 |
Regulation of cell-mediated neutralization of thrombin by antithrombin III
|
|
|
1986 |
41 |
S1 |
p. 57- 1 p. |
artikel |
260 |
Relationship between fatty acid composition of platelet membrane phospholipid and phostaglandin in biosynthesis in diabetes mellitus
|
|
|
1986 |
41 |
S1 |
p. 3- 1 p. |
artikel |
261 |
Relative insensitivity of epinephrine induced platelet aggregation to prostacyclin (PGI2)
|
|
|
1986 |
41 |
S1 |
p. 169- 1 p. |
artikel |
262 |
Release of fibrinopeptides A and B and activation of factor XIII by isolated, immobilized B chain of thrombin
|
|
|
1986 |
41 |
S1 |
p. 5- 1 p. |
artikel |
263 |
Repartition of fibrinolytic abnormalities in patients with idiopathic deep vein thrombosis
|
|
|
1986 |
41 |
S1 |
p. 73- 1 p. |
artikel |
264 |
Reverse fibrin slide technique: A method for localization of plasminogen activator inhibitor activity in tissue sections
|
Kirchheimer, J.C. |
|
1986 |
41 |
S1 |
p. 108- 1 p. |
artikel |
265 |
Role of GPIIb/IIIa as well as GPIb in von Willebrand factor-mediated platelet adhesion to collagen
|
|
|
1986 |
41 |
S1 |
p. 138- 1 p. |
artikel |
266 |
Secretion of protein-kinase activity by stimulated platelets
|
|
|
1986 |
41 |
S1 |
p. 120- 1 p. |
artikel |
267 |
Segmental wall motion analysis after early intravenous urokinase in evolving myocardial infarction
|
|
|
1986 |
41 |
S1 |
p. 105- 1 p. |
artikel |
268 |
Selected hemostasis parameters and survival in burn patients
|
DePoli, P.A. |
|
1986 |
41 |
S1 |
p. 153- 1 p. |
artikel |
269 |
Sensitivity and specifity of thrombin generation and platelet secretion in patients with malignancy
|
Scharf, R.E. |
|
1986 |
41 |
S1 |
p. 115- 1 p. |
artikel |
270 |
Serum fatty acids and platelet reactivity
|
|
|
1986 |
41 |
S1 |
p. 1- 1 p. |
artikel |
271 |
Severe heparin and pentosan polysulfate - induced thrombocytopenias : Clinical aspects - in vitro effects of pentosan polysulfate, low molecular weight (LMW) heparins and oligosaccharides
|
Borg, J.Y. |
|
1986 |
41 |
S1 |
p. 96- 1 p. |
artikel |
272 |
Shear stress activation of platelets and von Willebrand's high molecular weight multimers
|
|
|
1986 |
41 |
S1 |
p. 139- 1 p. |
artikel |
273 |
Sleep dependent variations of heparin anti factor Xa plasma activity
|
|
|
1986 |
41 |
S1 |
p. 91- 1 p. |
artikel |
274 |
Some aspects of the regulation of megakaryocytopoiesis
|
|
|
1986 |
41 |
S1 |
p. 126- 1 p. |
artikel |
275 |
Spontaneous platelet aggregation, VWF-AG and fibrin as risk factors for new vascular occlusions in type I and II diabetes
|
Breddin, H.K. |
|
1986 |
41 |
S1 |
p. 154- 1 p. |
artikel |
276 |
Standardisation of the laser induced thrombosis model and evaluation of anti-thrombotic drugs
|
Seiffge, D. |
|
1986 |
41 |
S1 |
p. 113- 1 p. |
artikel |
277 |
Structural and immunological comparison of thrombospondin from platelets and colostrum
|
|
|
1986 |
41 |
S1 |
p. 55- 1 p. |
artikel |
278 |
Structural and immunological properties of myosin from human platelet external and internal membranes
|
|
|
1986 |
41 |
S1 |
p. 173- 1 p. |
artikel |
279 |
Structural requirements for the antagonism of PAF-acether induced platelet activation by triazolobenzodiazepines
|
|
|
1986 |
41 |
S1 |
p. 147- 1 p. |
artikel |
280 |
Study of blood clotting and fibrinolysis during r-TPA infusion in patients with acute myocardial infarction
|
|
|
1986 |
41 |
S1 |
p. 21- 1 p. |
artikel |
281 |
Subcellular distribution of vinculin in resting and activated platelets
|
Muszbek, L. |
|
1986 |
41 |
S1 |
p. 172- 1 p. |
artikel |
282 |
Subcutaneous enoxaparin as anticoagulant therapy in acute pulmonary embolism in man
|
Huet, Y. |
|
1986 |
41 |
S1 |
p. 79- 1 p. |
artikel |
283 |
Substitution of antithrombin III in acquired at-III deficiency
|
Breddin, H.K. |
|
1986 |
41 |
S1 |
p. 131- 1 p. |
artikel |
284 |
Substitution of antithrombin-III in patients with congenital at III-deficiency
|
Schramm, W. |
|
1986 |
41 |
S1 |
p. 130- 1 p. |
artikel |
285 |
Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. Clinical implications
|
Altman, R. |
|
1986 |
41 |
S1 |
p. 15- 1 p. |
artikel |
286 |
Synthetic heparin fragments : Tools to study the contribution of factor Xa inhibition to the antithrombotic effect
|
Choay, J. |
|
1986 |
41 |
S1 |
p. 95- 1 p. |
artikel |
287 |
The assembly of blood clotting complexes on membranes
|
|
|
1986 |
41 |
S1 |
p. 9- 1 p. |
artikel |
288 |
The basic wave: A method for studying early platelet-collagen interactions in whole blood. Study in normal and hypertriglyceridemic subjects
|
Vallés, J. |
|
1986 |
41 |
S1 |
p. 3- 1 p. |
artikel |
289 |
The case for thrombolytic therapy in deep vein thrombosis (DVT)?
|
|
|
1986 |
41 |
S1 |
p. 69- 1 p. |
artikel |
290 |
The clinical significance of measurement of platelet volume in disease
|
|
|
1986 |
41 |
S1 |
p. 125- 1 p. |
artikel |
291 |
The effect of dipyridamole and pentoxifylline on prostacyclin generation and platelet aggregation in patients with diffuse cerebrovascular insufficiency. Influence of the time of treatment
|
|
|
1986 |
41 |
S1 |
p. 142- 1 p. |
artikel |
292 |
The effect of heparin and other sulphated polysaccharides on the bleeding time: Possible relationship with lipase release
|
|
|
1986 |
41 |
S1 |
p. 117- 1 p. |
artikel |
293 |
The effect of iloprost (ZK 36,374) on white cell behaviour
|
|
|
1986 |
41 |
S1 |
p. 150- 1 p. |
artikel |
294 |
The effect of ionizing irradiation on the production of a potent neutrophil chemoattractant by cultured vascular endothelial cells
|
|
|
1986 |
41 |
S1 |
p. 133- 1 p. |
artikel |
295 |
The effect of phospholipids on purified human endothelial thrombomodulin
|
Freyssinet, J.-M. |
|
1986 |
41 |
S1 |
p. 77- 1 p. |
artikel |
296 |
The effect of plasma proteins on fibrin network structure
|
Nair, C.H. |
|
1986 |
41 |
S1 |
p. 4- 1 p. |
artikel |
297 |
The effect of transdermally applied iloprost (ZK36-374) on whole blood platelet aggregation
|
|
|
1986 |
41 |
S1 |
p. 151- 1 p. |
artikel |
298 |
The effect of zinc ions on the thrombin-binding capacity of fibrin
|
Hopmeier, P. |
|
1986 |
41 |
S1 |
p. 4- 1 p. |
artikel |
299 |
The effects of long-term cyclosporin a therapy post-renal transplantation on haemostasis
|
Cohen, H. |
|
1986 |
41 |
S1 |
p. 152- 1 p. |
artikel |
300 |
The in vivo effects of acaenocoumarol, phenprocoumon and warfarin on vitamin KO-reductase and vitamin K-dependent carboxylase activities in hepatic and non-hepatic tissues of the rat
|
|
|
1986 |
41 |
S1 |
p. 165- 1 p. |
artikel |
301 |
The prekallikrein-kinin system during deep vein thrombosis
|
|
|
1986 |
41 |
S1 |
p. 85- 1 p. |
artikel |
302 |
The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism
|
Korninger, C. |
|
1986 |
41 |
S1 |
p. 129- 1 p. |
artikel |
303 |
The prolongation of the platelet survival time mediated by ketanserin in rats
|
|
|
1986 |
41 |
S1 |
p. 61- 1 p. |
artikel |
304 |
Therapeutic range for control of oral anticoagulant therapy
|
|
|
1986 |
41 |
S1 |
p. 68- 1 p. |
artikel |
305 |
Therapy of DIC in the field of gynecology with an antithrombin III concentrate
|
Ikenou, T. |
|
1986 |
41 |
S1 |
p. 50- 1 p. |
artikel |
306 |
The reliability of APTT methods and the relationship to lipid composition and ultrastructure
|
Stevenson, K. |
|
1986 |
41 |
S1 |
p. 42- 1 p. |
artikel |
307 |
The role of aggregation and thromboxane A2 in the release of platelet alpha granules
|
Riess, H. |
|
1986 |
41 |
S1 |
p. 168- 1 p. |
artikel |
308 |
The role of cyclic nucleotides in the control of platelet aggregation in vitro and in vivo
|
|
|
1986 |
41 |
S1 |
p. 146- 1 p. |
artikel |
309 |
The role of lupus anticoagulant in habitual abortion
|
Carp, H.J.A. |
|
1986 |
41 |
S1 |
p. 97- 1 p. |
artikel |
310 |
The role of sialic acid in plasmin human fibrinogen degradation
|
Regañon, E. |
|
1986 |
41 |
S1 |
p. 30- 1 p. |
artikel |
311 |
The sensitivity of different coagulation reagents to the presence of lupus anticoagulants
|
|
|
1986 |
41 |
S1 |
p. 77- 1 p. |
artikel |
312 |
The vascular plasminogen activator activity present in human plasma after venous occlusion circulates as a vPA-inhibitor complex
|
Boutière, B. |
|
1986 |
41 |
S1 |
p. 20- 1 p. |
artikel |
313 |
Three cases of fletcher factor deficiency in an Iranian Jewish family with various allergic and/or rheumatoid features
|
|
|
1986 |
41 |
S1 |
p. 37- 1 p. |
artikel |
314 |
Thrombocytopenia associated with a Waldenstrom's IgM that binds to platelets and DNA
|
|
|
1986 |
41 |
S1 |
p. 22- 1 p. |
artikel |
315 |
Thrombolytic therapy of deep venous thrombosis (DVT)
|
|
|
1986 |
41 |
S1 |
p. 79- 1 p. |
artikel |
316 |
Thrombolytic therapy with heparin-hemoclar∗ association
|
Pinot, J.J. |
|
1986 |
41 |
S1 |
p. 107- 1 p. |
artikel |
317 |
Thrombomodulin and the activation of protein C
|
Guillin, M.C. |
|
1986 |
41 |
S1 |
p. 63- 1 p. |
artikel |
318 |
Thrombosis prophylaxis with LMW heparin and sodium heparin in patients with total hip replacement
|
|
|
1986 |
41 |
S1 |
p. 83- 1 p. |
artikel |
319 |
Thrombosis prophylaxis with low molecular weight heparin in trauma surgery
|
|
|
1986 |
41 |
S1 |
p. 84- 1 p. |
artikel |
320 |
Thrombospondin forms a surface for plasminogen activation by tissue activator: Formation of a ternary complex
|
|
|
1986 |
41 |
S1 |
p. 54- 1 p. |
artikel |
321 |
Thrombospondin inhibits adhesion of endothelial cells to substrata
|
|
|
1986 |
41 |
S1 |
p. 132- 1 p. |
artikel |
322 |
Thrombospondin macromolecular complexes
|
|
|
1986 |
41 |
S1 |
p. 7- 1 p. |
artikel |
323 |
Thromboxane, beta-thrombglobin, prostacyclin, diabetes & atherosclerosis
|
|
|
1986 |
41 |
S1 |
p. 26- 1 p. |
artikel |
324 |
Time course of the effects of some heparin(oid)s on bleeding and of the interactions of these substances with factor Xa and thrombin in rats
|
Hobbelen, P.M.J. |
|
1986 |
41 |
S1 |
p. 118- 1 p. |
artikel |
325 |
Time varying turbulent fluid characteristics and vascular endothelium
|
Einav, S. |
|
1986 |
41 |
S1 |
p. 132- 1 p. |
artikel |
326 |
Transacylase-catalyzed biosynthesis of arachidonic acid containing ether phospholipids in human platelets
|
|
|
1986 |
41 |
S1 |
p. 119- 1 p. |
artikel |
327 |
Treatment of acute thrombosis in cases of antithrombin III deficiency
|
Tengborn, L. |
|
1986 |
41 |
S1 |
p. 49- 1 p. |
artikel |
328 |
Treatment of deep vein thrombosis by a very low molecular weight heparin fragment (CY 222) : A dose range study
|
|
|
1986 |
41 |
S1 |
p. 82- 1 p. |
artikel |
329 |
Treatment of deep vein thrombosis (D.V.T.) at home, diagnosed by Impedance Plethysmography (I.P.G.), with oral anticoagulants only
|
|
|
1986 |
41 |
S1 |
p. 74- 1 p. |
artikel |
330 |
Treatment of deep vein thrombosis (DVT) with LMWH CY 222. Modifications of biological parameters
|
Aillaud, M.F. |
|
1986 |
41 |
S1 |
p. 83- 1 p. |
artikel |
331 |
Turnover of antithrombin III and heparin cofactor II in baboons treated with heparin and pentosan polysulfate
|
|
|
1986 |
41 |
S1 |
p. 58- 1 p. |
artikel |
332 |
Two new cases of congenital dysfibrinogenemia with impaired aggregation of monomers: Fibrinogens Salamanca II and Santander I
|
Fernández, J. |
|
1986 |
41 |
S1 |
p. 6- 1 p. |
artikel |
333 |
UDCG 115 a benzimidazo-pyridazinone compound with cardiovascular activity inhibits platelet thrombus formation
|
Bastida, E. |
|
1986 |
41 |
S1 |
p. 145- 1 p. |
artikel |
334 |
Ultrastructural modifications of platelet plasma-membrane in vascular disease patients and the effect of a carbochromen derivative
|
Bianciardi, G. |
|
1986 |
41 |
S1 |
p. 142- 1 p. |
artikel |
335 |
Unfractionated heparin vs low molecular weight heparin fraction (LMWH) : An experimental study during neurosurgery
|
Huet, Y. |
|
1986 |
41 |
S1 |
p. 93- 1 p. |
artikel |
336 |
Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammapathy
|
López-Fernández, M.F. |
|
1986 |
41 |
S1 |
p. 101- 1 p. |
artikel |
337 |
Unresolved issues concerning thrombolytic therapy
|
|
|
1986 |
41 |
S1 |
p. 128- 1 p. |
artikel |
338 |
Uraemic plasma does not support the adhesion of normal platelets to the vessel subendothelium
|
Castillo, R. |
|
1986 |
41 |
S1 |
p. 102- 1 p. |
artikel |
339 |
Visual prognosis following treatment of central retinal vessel occlusion by streptokinase
|
Peternel, P. |
|
1986 |
41 |
S1 |
p. 110- 1 p. |
artikel |
340 |
Vitamin K-dependent carboxylase in human vessel wall
|
|
|
1986 |
41 |
S1 |
p. 134- 1 p. |
artikel |
341 |
Von Willebrand factor multimer patterns in pregnancy-induced hypertension
|
Brenner, B. |
|
1986 |
41 |
S1 |
p. 100- 1 p. |
artikel |
342 |
Whole blood thromboxane and prostacyclin production in familial hypercholesterolemia
|
Wessels, P. |
|
1986 |
41 |
S1 |
p. 29- 1 p. |
artikel |
343 |
Zinc ingestion increases platelet sensitivity
|
|
|
1986 |
41 |
S1 |
p. 28- 1 p. |
artikel |